PubMed · 2065793
Progesterone administration by nasal spray.
Abstract
The bioavailability and the clinical usefulness of the P administered by nasal spray were investigated. Ten healthy menopausal women received an IN spray administration (4 doses of an oleic P solution 20 mg/mL, corresponding to nearly 11.2 mg of P) and the circulating P levels were calculated. Sixty minutes after administration, the maximum concentration (CMax, 3.75 +/- 0.214 ng/mL) was reached. High P levels (greater than 2 ng/mL) lasted until 360 minutes, and the AUC 0 to 720 was 1,481.6 +/- 343 ng.h/mL. Progesterone administration by spray formulation has proven to be effective in reaching therapeutic levels and to be acceptable to patients and, probably, clinically safe.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E Cicinelli, G Ragno, I Cagnazzo, F Fanelli, C Vetuschi, S Schonauer. 1991. Progesterone administration by nasal spray.. https://doi.org/10.1016/s0015-0282(16)54433-1
Cite the original work for its findings. Save a collection to share your selection of sources.